Encouraging the use of pre-exposure prophylaxis (PrEP) depends on the way that HIV risk is communicated to subgroups that are traditionally at the highest risk. A new study found that interest in PrEP ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today ...
At the Bronx Museum of the Arts, the sculptor’s first solo museum show, filled with autobiographical and religion-influenced ...
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...
Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...
For 11 FDA-approved checkpoint inhibitors, we studied quarterly average sales prices from public Medicare spending files from Q3 2015 to Q1 2024; prices were standardized to cost per 28-day treatment ...